|
|
|
|
|
|
|
How to Avoid False Negatives in Early CNS Development
|
Promising CNS compounds may be stopped too early when pharmacological effects go undetected. Learn why false negatives occur in early clinical development and explore six practical strategies to improve signal detection, strengthen confidence in pharmacodynamic findings, and support more informed go/no-go decisions. Read the article.
|
|
|
|
|
|
|
|
Where The FDA And EMA Stand On Digital Endpoints
|
|
Guest Column | By Anita Burrell, Anita Burrell Consulting LLC
|
In part two of this series on digital endpoints, consultant Anita Burrell reviews the extent of their regulatory acceptance and discusses how to ensure data produced from digital technologies satisfies regulators.
|
|
|
|
|
|
|
|
|
|
|
|
Delivering Value In Clinical Trial Services
|
|
Webinar | Thermo Fisher Scientific
|
Gain insights into managing the complexity of global trials, balancing accelerated timelines with compliance, using advanced technologies, and leveraging partnerships to ensure seamless operations.
|
|
|
|
|
|
Elevating IDS Practice Through Continuing Education
|
|
Webinar | McCreadie Group
|
Discover how leading IDS teams are using automation and standardized digital workflows to streamline protocol management, reduce errors, improve efficiency, and strengthen research operations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From Data Delays To Decision Speed
|
|
Article | Endpoint Clinical
|
The biggest risk in modern trials isn’t missing data. It’s delayed insight. Discover how real-time intelligence helps teams act faster, reduce risk, and improve trial execution.
|
|
|
|
|
|
Flexible Supply Strategies For Complex Clinical Trials
|
|
Webinar | Catalent
|
Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.
|
|
|
|
|
|
|
| Connect With Clinical Leader: |
|
|
|
|